title: Lovastatin may reduce the risk of erectile dysfunction following radiation therapy for prostate cancer.
authors: a Department of Radiation Oncology , Virginia Commonwealth University , Richmond , VA , USA.
authors: Mitchell S
authors: MS
authors: Anscher
authors: a Department of Radiation Oncology , Virginia Commonwealth University , Richmond , VA , USA.|b Hunter Holmes McGuire Veterans Affairs Medical Center , Richmond , VA , USA.
authors: Michael G
authors: MG
authors: Chang
authors: a Department of Radiation Oncology , Virginia Commonwealth University , Richmond , VA , USA.|b Hunter Holmes McGuire Veterans Affairs Medical Center , Richmond , VA , USA.
authors: Drew
authors: D
authors: Moghanaki
authors: a Department of Radiation Oncology , Virginia Commonwealth University , Richmond , VA , USA.
authors: Mihaela
authors: M
authors: Rosu
authors: a Department of Radiation Oncology , Virginia Commonwealth University , Richmond , VA , USA.
authors: Ross B
authors: RB
authors: Mikkelsen
authors: c The Massey Cancer Center, Virginia Commonwealth University , Richmond , VA , USA.
authors: Diane
authors: D
authors: Holdford
authors: c The Massey Cancer Center, Virginia Commonwealth University , Richmond , VA , USA.
authors: Vicki
authors: V
authors: Skinner
authors: d Department of Surgery (Urology) , Virginia Commonwealth University , Richmond , VA , USA.
authors: B Mayer
authors: BM
authors: Grob
authors: e Department of Medicine , Virginia Commonwealth University , Richmond , VA , USA.
authors: Arun
authors: A
authors: Sanyal
authors: f Department of Biostatistics , Virginia Commonwealth University , Richmond , VA , USA.
authors: Aiping
authors: A
authors: Wang
authors: f Department of Biostatistics , Virginia Commonwealth University , Richmond , VA , USA.
authors: Nitai D
authors: ND
authors: Mukhopadhyay
mesh_terms: D001918:Brachytherapy / Q000009:adverse effects*; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D005500:Follow-Up Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008148:Lovastatin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D012307:Risk Factors
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin